Piqur Therapeutics Ag

Calculating rank

USPTO Granted Patents = 4

EPO Patents = 3

Forward Citations = 11

Loading Chart...

9 inventors (with patents filed for the assignee):

Paul Hebeisen (4 out of 49 patents)

Florent Beaufils (4 out of 12 patents)

Jean-Baptiste Langlois (3 out of 6 patents)

4. Vladimir Cmiljanovic (2 out of 4 patents)

5. Thomas Bohnacker (2 out of 3 patents)

6. Matthias Wymann (2 out of 6 patents)

7. Denise Rageot (1 out of 4 patents)

8. Alexander Sele (1 out of 3 patents)

9. Eileen Jackson (1 out of 1 patent)

4 patents: Sort by Forward Citations

1. 10766874 - Manufacturing process for triazine, pyrimidine and pyridine derivatives (2020-09-08),

2. 10640516 - Difluoromethyl-aminopyridines and difluoromethyl-aminopyrimidines (2020-05-05),

3. 10100031 - Manufacturing process for triazine, pyrimidine and pyridine derivatives (2018-10-16),

4. 9556203 - Conformationally restricted P13K and mTOR inhibitors (2017-01-31),

Company Overview

Piqur Therapeutics Ag is a Swiss biotechnology company focused on the development of innovative cancer treatments. They specialize in targeted therapies for various types of cancer, with a particular emphasis on precision medicine and personalized treatment approaches. Their mission is to improve the lives of patients by advancing the field of oncology through cutting-edge research and advanced technology.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

4 Patents

#77 in Basel

#2,006 in Switzerland

Basel, Switzerland

Piqur Therapeutics Ag

Forward Citations = 11

9 inventors:

Paul Hebeisen (4 out of 49 patents)

Florent Beaufils (4 out of 12 patents)

Jean-Baptiste Langlois (3 out of 6 patents)

4. Vladimir Cmiljanovic (2 out of 4 patents)

5. Thomas Bohnacker (2 out of 3 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Piqur Therapeutics Ag. Retrieved from https://idiyas.com/company/piqur-therapeutics-ag

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

3 patents (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]